Cognition Therapeutics LLC Rockville, MD - 20850

Cognition Therapeutics LLC is categorized under Commercial Biotechnical Research in Rockville, MD and active since 2004.

Cognition Therapeutics LLC was established in 2004, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.

If you are seeking more information, feel free to contact Greg Prince at the company’s single location by writing to 9601 Medical Center Drive, Rockville, Maryland MD 20850 or by phoning (301) 294-7186. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Cognition Therapeutics LLC
Contact Person: Greg Prince
Address: 9601 Medical Center Drive, Rockville, Maryland 20850
Phone Number: (301) 294-7186
Annual Revenue (USD): $500.000 to $999.999
Founded: 2004
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Biotechnical Research
SIC Code: 8731
NAICS Code: 541711
Share This Business:

Cognition Therapeutics LLC was started in 2004 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Greg Prince for inquiries that concern Cognition Therapeutics LLC by calling the company number (301) 294-7186, as your correspondence is most welcome. Additionally, the physical location of the single location of Cognition Therapeutics LLC can be found at the coordinates 39.10232,-77.19607 as well as the street address 9601 Medical Center Drive in Rockville, Maryland 20850.

For its online presence, you may visit Cognition Therapeutics LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.